Developing new cancer therapies for patients with high-risk tumors
Cancer research developed into candidate drugs
Our goal is to develop a new cancer therapy for patients with aggressive high-risk tumors
Fiftheen years of cancer research has generated potential candidate drugs that target the so called “undruggable” MYC, the main driver in more than 50% of all cancers.
Our vision is to create a new cancer therapy"
Our vision is to develop a new cancer therapy for patients with high-risk tumors
News from MyCural
As a start-up company taking part in networking events, the UIC business incubator and pharma conferences, we are glad to present our news here.
En av årets vinnare i Bona Postulata 2023
Bona Postulata är ett lokalt näringslivspris som vill uppmuntra uppländska företag som inte är så
Three holding companies invest in MyCural
We are happy to have the holding companies as investors and we are very thankful for their help with business strategy, networks and support.